Methotrexate Clinical Trials

• A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis (IMAGE)
  ClinicalTrials.gov Identifier: NCT00299104 - Active, not recruiting
  Rheumatoid Arthritis
  
• Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and Cytarabine
  ClinicalTrials.gov Identifier: NCT00503594 - Recruiting
  Lymphoma
  
• A Study to Evaluate Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00299130 - Active, not recruiting
  Rheumatoid Arthritis
  
• Combination Therapy with Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00037102 - Active, not recruiting
  Multiple Sclerosis
  
• Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00195494 - Active, not recruiting
  Rheumatoid Arthritis
  
• A research study in patients with moderate to severe rheumatoid arthritis to observe the safety and effectiveness of MRA (investigational drug) combined with methotrexate compared to placebo combined with methotrexate
  ClinicalTrials.gov Identifier: NCT00106548 - Active, not recruiting
  Rheumatoid Arthritis
  
• To study the safety (free of harmful side effects) and effectiveness (prevention of structural joint damage) of MRA, in combination with methotrexate, compared to placebo in combination with methotrexate in rheumatoid arthritis patients
  ClinicalTrials.gov Identifier: NCT00106535 - Active, not recruiting
  Rheumatoid Arthritis
  
• COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial)
  ClinicalTrials.gov Identifier: NCT00132899 - Active, not recruiting
  Crohn''s Disease
  
• Prevention of Methotrexate Induced Nephrotoxicity and Prolonged Drug Elimination Time With 12 Hours Prehydration
  ClinicalTrials.gov Identifier: NCT00570817 - Recruiting
  Methotrexate Induced Nephrotoxicity
  
• Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00002487 - Active, not recruiting
  recurrent ovarian epithelial cancer
  
• Study Evaluating ERB-041 with Methotrexate in Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00141830 - Active, not recruiting
  Rheumatoid Arthritis
  
• Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis
  ClinicalTrials.gov Identifier: NCT00004686 - Active, not recruiting
  Giant Cell Arteritis
  
• Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00161655 - Active, not recruiting
  Plaque psoriasis
  
• Assessment of Rituximab''s Immunomodulatory Synovial Effects (The ARISE Study)
  ClinicalTrials.gov Identifier: NCT00147966 - Recruiting
  Rheumatoid Arthritis; active disease despite concomitant methotrexate
  
• High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00082797 - Active, not recruiting
  adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
  
• Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00083031 - Active, not recruiting
  recurrent breast cancer; stage IV breast cancer
  
• Rapamycin Vs Methotrexate in Diffuse SSc
  ClinicalTrials.gov Identifier: NCT00241189 - Active, not recruiting
  Systemic Sclerosis
  
• Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00074191 - Active, not recruiting
  intraocular lymphoma; primary central nervous system lymphoma
  
• Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00074178 - Active, not recruiting
  primary central nervous system lymphoma; intraocular lymphoma
  
• Bevacizumab with Or Without Cyclophosphamide and Methotrexate: a Pilot Study in Women with Operable Breast Cancer
  ClinicalTrials.gov Identifier: NCT00121134 - Recruiting
  Breast Cancer
  
• WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated Vasculitides
  ClinicalTrials.gov Identifier: NCT00349674 - Active, not recruiting
  Systemic Wegener's Granulomatosis
  
• Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia
  ClinicalTrials.gov Identifier: NCT00003702 - Active, not recruiting
  Hydatidiform Mole; uterine choriocarcinoma; nonmetastatic gestational trophoblastic tumor; good prognosis metastatic gestational trophoblastic tumor
  
• Fludarabine and Melphalan Followed by Tacrolimus and Methotrexate in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Relapsed Lymphoma
  ClinicalTrials.gov Identifier: NCT00121186 - Active, not recruiting
  adult Hodgkin''s lymphoma; adult non-Hodgkin''s lymphoma
  
• Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT
  ClinicalTrials.gov Identifier: NCT00506922 - Active, not recruiting
  Leukemia; Lymphoma
  
• Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00357084 - Active, not recruiting
  Cancer
  
• Evaluate Whether a Course of Methotrexate in Psoriasis Patients Treated With Efalizumab is Safe and Increases Efficacy
  ClinicalTrials.gov Identifier: NCT00368654 - Active, not recruiting
  Psoriasis
  
• Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who are Undergoing Donor Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00089037 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer
  
• Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003536 - Recruiting
  stage IV breast cancer; recurrent breast cancer
  
• A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  ClinicalTrials.gov Identifier: NCT00316771 - Active, not recruiting
  Rheumatoid Arthritis
  
• A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate
  ClinicalTrials.gov Identifier: NCT00243412 - Active, not recruiting
  Rheumatoid Arthritis
  
• A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  ClinicalTrials.gov Identifier: NCT00422383 - Active, not recruiting
  Rheumatoid Arthritis
  
• A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate
  ClinicalTrials.gov Identifier: NCT00282308 - Active, not recruiting
  Rheumatoid Arthritis
  
• A Study of the Safety and Efficacy of Intravenous CNTO 148 (Golimumab) in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
  ClinicalTrials.gov Identifier: NCT00361335 - Active, not recruiting
  Rheumatoid Arthritis
  
• A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Therapies.
  ClinicalTrials.gov Identifier: NCT00462345 - Active, not recruiting
  Rheumatoid Arthritis
  
• A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Agents.
  ClinicalTrials.gov Identifier: NCT00504777 - Active, not recruiting
  Rheumatoid Arthritis
  
• A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate
  ClinicalTrials.gov Identifier: NCT00345748 - Active, not recruiting
  Rheumatoid Arthritis
  
• Safety and Efficacy of Rituximab in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Respond Poorly to Anti-TNFα Therapies
  ClinicalTrials.gov Identifier: NCT00468546 - Active, not recruiting
  Arthritis, Rheumatoid
  
• Tretinoin, Cytarabine, and Daunorubicin With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003934 - Active, not recruiting
  untreated adult acute myeloid leukemia; untreated childhood acute myeloid leukemia and other myeloid malignancies; ...
  
• The Influence of Methotrexate on the Metabolism and Vascular Effects of Adenosine in Humans
  ClinicalTrials.gov Identifier: NCT00184886 - Completed
  Methotrexate; Vasodilation
  
• Treatment of Early RA: Minocycline in Combination With Methotrexate vs Methotrexate Alone
  ClinicalTrials.gov Identifier: NCT00579644 - Completed
  Rheumatoid Arthritis
  
• Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients
  ClinicalTrials.gov Identifier: NCT00280917 - Active, not recruiting
  Rheumatoid Arthritis
  
• Chemotherapy and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00002547 - Active, not recruiting
  Leukemia
  
• Methotrexate in the Treatment of Axial Spondyloarthritis
  ClinicalTrials.gov Identifier: NCT00298012 - Recruiting
  Spondylarthropathies; Spondylitis, Ankylosing
  
• Voraxaze for Delayed Methotrexate Clearance
  ClinicalTrials.gov Identifier: NCT00424645 - Recruiting
  Hematologic Malignancy; Solid Tumor
  
• BG9924 in Combination With Methotrexate Extension of Study 104RA203
  ClinicalTrials.gov Identifier: NCT00523328 - Recruiting
  Rheumatoid Arthritis
  
• Combination Chemotherapy in Treating Patients With Merkel Cell Cancer
  ClinicalTrials.gov Identifier: NCT00003549 - Active, not recruiting
  neuroendocrine carcinoma of the skin
  
• Study to Assess Efficacy of Tacrolimus + Methotrexate Vs. Placebo + Methotrexate in Treatment of Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00036153 - Completed
  Rheumatoid Arthritis
  
• Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00003056 - Active, not recruiting
  Lymphoma; Leukemia
  
• Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002471 - Active, not recruiting
  Lymphoma; Leukemia
  
• A Study of the Safety and Efficacy of Golimumab in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
  ClinicalTrials.gov Identifier: NCT00264550 - Active, not recruiting
  Rheumatoid Arthritis
  
• Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma
  ClinicalTrials.gov Identifier: NCT00003187 - Active, not recruiting
  Lymphoma; Leukemia
  
• A Study to Observe Safety and Effectiveness of MRA (Tocilizumab) Compared to Methotrexate (MTX) alone for Patients with Active Rheumatoid Arthritis (RA)
  ClinicalTrials.gov Identifier: NCT00109408 - Active, not recruiting
  Rheumatoid Arthritis
  
• A Study of the Safety and Efficacy of Golimumab in Patients With Rheumatoid Arthritis That Are Methotrexate-Naive
  ClinicalTrials.gov Identifier: NCT00264537 - Active, not recruiting
  Rheumatoid Arthritis
  
• Mannitol Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain
  ClinicalTrials.gov Identifier: NCT00397501 - Active, not recruiting
  Brain and Central Nervous System Tumors; Breast Cancer; Cognitive/Functional Effects; Drug Toxicity; Psychosocial Effects/Treatment
  
• A Randomized Controlled Study of Postoperative Adjuvant Therapy of UFT Compared with CMF in Breast Cancer (NSAS-BC)
  ClinicalTrials.gov Identifier: NCT00152191 - Active, not recruiting
  Breast Cancer
  
• Two-Dose Methotrexate for Ectopic Pregnancy
  ClinicalTrials.gov Identifier: NCT00194272 - Active, not recruiting
  Ectopic Pregnancy
  
• Methotrexate in Ankylosing Spondylitis (MTX in AS)
  ClinicalTrials.gov Identifier: NCT00243750 - Active, not recruiting
  Ankylosing Spondylitis
  
• Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00005641 - Active, not recruiting
  Leukemia; Multiple Myeloma
  
• Efficacy and Safety Study of Rituximab in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00074438 - Active, not recruiting
  Rheumatoid Arthritis
  
• High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma
  ClinicalTrials.gov Identifier: NCT00287924 - Recruiting
  Brain and Central Nervous System Tumors
  
• A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background Methotrexate
  ClinicalTrials.gov Identifier: NCT00266227 - Active, not recruiting
  Rheumatoid Arthritis
  
• Induction Therapy with a Single High Dose Bolus of Intravenous Methotrexate with Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting with a First Acute Demyelinating Event.
  ClinicalTrials.gov Identifier: NCT00037115 - Not yet recruiting
  Demyelinating Disorders; Multiple Sclerosis; Optic Neuritis; Myelitis; Neuritis
  
• Bortezomib Plus Tacrolimus and Methotrexate to Prevent GVHD After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00369226 - Recruiting
  Hematologic Malignancies
  
• Phase 2 Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive ALL
  ClinicalTrials.gov Identifier: NCT00130195 - Active, not recruiting
  Acute Lymphoblastic Leukemia
  
• Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas
  ClinicalTrials.gov Identifier: NCT00278278 - Recruiting
  Brain and Central Nervous System Tumors
  
• Safety Study of SCIO-469 to treat Patients with Active Rheumatoid Arthritis Receiving Methotrexate
  ClinicalTrials.gov Identifier: NCT00043732 - Active, not recruiting
  Arthritis, Rheumatoid
  
• A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate Neurotoxicity
  ClinicalTrials.gov Identifier: NCT00176553 - Recruiting
  Neurotoxicity Syndromes
  
• Treatment With High Dose Methotrexate in Patients With Eosinophilic Fasciitis
  ClinicalTrials.gov Identifier: NCT00441961 - Recruiting
  Fasciitis
  
• Reduction of Immunosuppression Plus Interferon alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant
  ClinicalTrials.gov Identifier: NCT00002657 - Active, not recruiting
  Lymphoma; Multiple Myeloma
  
• Efficacy and Safety of TMI-005 in Subjects with Active Rheumatoid Arthritis on a Background of Methotrexate
  ClinicalTrials.gov Identifier: NCT00095342 - Active, not recruiting
  Rheumatoid Arthritis
  
• The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)
  ClinicalTrials.gov Identifier: NCT00251641 - Recruiting
  Psoriasis
  
• Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00018954 - Active, not recruiting
  Lymphoma; Leukemia
  
• A Study of the Use of Methotrexate in the Treatment of Chronic Idiopathic Urticaria
  ClinicalTrials.gov Identifier: NCT00189878 - Recruiting
  Urticaria
  
• Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003910 - Recruiting
  stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; ...
  
• Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy
  ClinicalTrials.gov Identifier: NCT00005988 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• The Comparative Trial of UFT + TAM with CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)
  ClinicalTrials.gov Identifier: NCT00152178 - Active, not recruiting
  Breast Cancer
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Primary CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00003061 - Active, not recruiting
  primary central nervous system lymphoma
  
• A Safety Study of Escalating Doses of PRO70769 for Subjects with Moderate to Severe Rheumatoid Arthritis Receiving Stable Doses of Concomitant Methotrexate
  ClinicalTrials.gov Identifier: NCT00077870 - Active, not recruiting
  Rheumatoid Arthritis
  
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002665 - Active, not recruiting
  Thrombocytopenia; Leukemia, Lymphocytic; Neutropenia
  
• AVONEX® Combination Trial - "ACT"
  ClinicalTrials.gov Identifier: NCT00112034 - Active, not recruiting
  Multiple Sclerosis, Relapsing-Remitting
  
• High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002784 - Active, not recruiting
  Breast Cancer
  
• SPRiNG: SCIO-469 Patients with Rheumatoid Arthritis Not Receiving Methotrexate
  ClinicalTrials.gov Identifier: NCT00089921 - Active, not recruiting
  Rheumatoid Arthritis
  
• Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00075725 - Recruiting
  untreated childhood acute lymphoblastic leukemia; B-cell childhood acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia; ...
  
• Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002532 - Active, not recruiting
  recurrent adult acute lymphoblastic leukemia
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00002831 - Active, not recruiting
  Leukemia, Myeloid; Leukemia, Myeloid, Chronic
  
• Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX
  ClinicalTrials.gov Identifier: NCT00360685 - Recruiting
  Mucositis; Graft-Versus-Host Disease
  
• Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis
  ClinicalTrials.gov Identifier: NCT00291915 - Recruiting
  Rheumatoid Arthritis; Arthritis
  
• Methotrexate, Leucovorin, Rituximab, and Highly Active Antiretroviral Therapy in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma
  ClinicalTrials.gov Identifier: NCT00304044 - Recruiting
  Lymphoma; Neurotoxicity
  
• Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002499 - Active, not recruiting
  recurrent childhood acute lymphocytic leukemia
  
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00005596 - Active, not recruiting
  untreated childhood acute lymphoblastic leukemia
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
  ClinicalTrials.gov Identifier: NCT00003632 - Active, not recruiting
  primary central nervous system lymphoma
  
• Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003592 - Active, not recruiting
  stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving Methotrexate
  ClinicalTrials.gov Identifier: NCT00369928 - Recruiting
  Rheumatoid Arthritis
  
• Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00413660 - Recruiting
  Arthritis, Rheumatoid
  
• Safety and Efficacy of Intravenous ACZ885 and Oral Methotrexate Therapy in Patients With Early Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00487825 - Recruiting
  Rheumatoid Arthritis
  
• A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Continuing Methotrexate Treatment (STAGE)
  ClinicalTrials.gov Identifier: NCT00406419 - Recruiting
  Rheumatoid Arthritis
  
• A Study to Evaluate the Safety and Efficacy of Ocrelizumab in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis (FILM)
  ClinicalTrials.gov Identifier: NCT00485589 - Recruiting
  Rheumatoid Arthritis
  
• Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and Cisplatin
  ClinicalTrials.gov Identifier: NCT00516750 - Recruiting
  Bladder Cancer
  
• A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis, With an Inadequate Response to Methotrexate
  ClinicalTrials.gov Identifier: NCT00409838 - Recruiting
  Rheumatoid Arthritis
  
• A Pharmacokinetic and Pharmacodynamic Study of MabThera (Rituximab) Plus Methotrexate in Patients With Rheumatoid Arthritis (RA)
  ClinicalTrials.gov Identifier: NCT00422942 - Recruiting
  Rheumatoid Arthritis